XTL Biopharmaceuticals Ltd. (XTLB) climbed 20.21% or 0.48 to $2.88. It is near to 74074 shares traded, which is 1165.6% compare to the average total volume 6355. The market cap of XTLB is $14.83 million. The year to date change is 18.57%. The 52 week price range is from $1.55 to $3.94. Price of XTLB have changed 10.09% during last week. It have changed 38.45% over last month, 30.43% over last 3 months, 39.53% over last 6 months and -9.09% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XTLB is 1.89. It is -34.38% below current price. The 200-day Moving Averages for XTLB is 1.92. It is -33.33% below current price. The 52-week High is 3.94. It is 36.81% from the current price. The 52-week Low is 1.55. It is -46.18% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of XTLB is 7.1 on 2018-09-28. Short % to float is 0.66%. There are some statistics of XTLB. It is has market cap $14.83 million. The share outstanding is 5.14 million. The average volume is 6355. The percent of top 15 Institution holding is 4.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XTLB is 59.53%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XTLB is 36.21%.